Summary
Increased expression of oestrogen (ER) and progesterone (PR) receptors have been reported in gastric adenocarcinoma, although results have been variable. Immunohistochemical staining methodologies, in particular in the detection of ER, have been inconsistent with many tumours being classified ER-negative. In this study we have used flow cytometry to quantify expression of ER and PR in gastric adenocarcinoma and examine their relationships with established prognostic indicators. Cytokeratin-positive cells obtained from tumour biopsies of 50 patients with gastric cancer and ten control patients were labelled with biotinylated ER or PR antibodies followed by streptavidin PE. Flow cytometry was seen to increase the detection of ER levels in gastric cancer with more receptor-positive patients in this study than in results published to date. We believe this is related to the sensitivity of the flow cytometric assay with the detection of small shifts in ER level detected using cytokeratin gating. On analysis, the data showed no significant correlations with tumour stage and grade, and no differences were seen between normal mucosa and gastric cancer samples.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Brotherick, I., Lennard, T. W. J., Wilkinson, S. E., Cook, S., Angus, B. & Shenton, B. K. (1994). A flow cytometric method for the measurement of epidermal growth factor receptor: a comparison with the radio-ligand binding assay. Cytometry 16: 262–269.
Brotherick, I., Lennard, T. W. J., Cook, S., Johnstone, R., Angus, B., Winthereik, M. P. & Shenton, B. K. (1995a). Use of the biotinylated antibody DAKO-ER 1D5 to measure oestrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells. Cytometry 20: 74–80.
Brotherick, I., Shenton, B. K. & Lennard, T. W. J. (1995b). Are fine-needle aspirates representative of the underlying solid tumour? A comparison of receptor levels, ploidy, and the influence of cytokeratin gates. Br J Cancer 72: 732–737.
Cohen, O., Brugal, G., Seigneurin, D. & Demongeot, J. (1988). Image cytometry of estrogen receptors in breast carcinomas. Cytometry 9: 579–587.
Furukawa, H., Iwanaga, T., Koyama, H. & Taniguchi, H. (1982). Effect of sex hormone on carcinogenisis in the stomach of rats. Cancer Res 42: 5181–5182.
Harrison, J. D., Watson, S. & Morris, D. L. (1989a). The effect of oestradiol and tamoxifen on the growth of human gastric cancer cell lines. Cancer 63: 2148–2151.
Harrison, J. D., Morris, D. L., Ellis, I. O., Jones, J. A. & Jackson, I. (1989b). The effect of Tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 64: 1007–1010.
Harrison, J. D., Jones, J. A., Ellis, I. O. & Morris, D. L. (1991). Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br J Surg 78: 334–336.
Howell, A., Barnes, D. M., Harland, R. N., Redford, J., Bramwell, V. H. & Wilkinson, M. J. (1984). Steroid hormone receptors and survival after first relapse in breast cancer. Lancet 1: 588–591.
Ismail, T., Baker, P., Hale, C., Fielding, J. W. L. & Hallissey, M. T. (1994). Oestrogen receptors in gastric cancer: international differences. Eur J Surg Oncol 20: 512
Kitaoka, H. (1983). Sex hormone dependency and endocrine therapy for patients with diffuse carcinoma of the stomach. Jpn J Cancer Chemother 10: 2453–2460.
Kohigashi, K., Fukuda, Y. & Imura, H. (1987). Estrogen receptors in hepatocellular carcinoma: is endocrine therapy for hepatocellular carcinoma likely to be effective? Gastroenterol Jpn 22: 322–330.
Kojima, O. & Takahashi, T. (1986). Endocrine therapy for scirrhous carcinoma of the stomach. Jpn J Cancer Chemother 13: 2526–2531.
Kojima, O., Takahashi, T., Kawakami, S., Uehara, Y. & Matsui, M. (1991). Localisation of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer 67: 2401–2406.
Kune, G. A. & Hunt, R. F. (1984). Oestrogen receptors in cystadenocarcinoma of the pancreas. Aust NZ J Surg 54: 321–323.
McClendon, J. E., Appleby, D., Claudon, D. B., Donegan, W. L. & Decosse, J. J. (1977). Colonic neoplasms: tissue estrogen receptor and carcinoembryonic antigen. Arch Surg 122: 240–241.
Nogha, K., Katsumata, T. & Ishiwata, K. (1987). Experimental and clinical study on chemoendocrine therapy for gastric cancer. J Jpn Surg Soc 88: 1109–1112.
Sica, V., Nola, E., Contieri, E., Bova, R., Masucci, M. T., Medici, N., Petrillo, A., Weisz, A., Molinari, A. M. & Puca, G. A. (1984). Estradiol and progesterone receptors in malignant gastrointestinal tumours. Cancer Res 44: 4670–4674.
Singh, S., Poulsom, R., Wright, N. A., Sheppard, M. C. & Langman, M. J. S. (1997). Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer. Gut 40: 516–520.
Smith, D. E., Prentice, R., Thompson, D. J. & Herrman, W. L. (1975). Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293: 1164–1167.
Tokunaga, A., Nishi, K., Matsukura, N., Tanaka, N., Onda, M., Shirota, A., Asano, G. & Hayashi, K. (1986). Estrogen and progesterone receptors in gastric cancer,. Cancer 56: 1376–1379.
Walsh, P. C. & Hicks, L. L. (1979). Characterisation and measurement of androgen receptors in human prostatic tissue. Prog Clin Biol Res 33: 51–63.
Wu, C. W., Chang, H. M., Hsieh, M. C., Kao, H. L., Lui, W. Y., P’eng, F. K. & Chi, C. W. (1992a). The nontransformed progesterone and estrogen receptors in gastric cancer. Gastroenterology 102: 1639–1646.
Wu, C. W., Tsay, S. H., Chang, T. J., Chang, H. M., Hsieh, M. C., Lui, W. Y., P’eng, F. K. & Chi, C. W. (1992b). Clinicopathologic comparisons between estrogen receptor-positive and –negative gastric cancers. J Surg Oncol 51: 231–235.
Yamamoto, K. R. & Alberts, B. M. (1999). Steroid receptors: elements for modulation of eukaryotic transcription. Ann Rev Bioch 45: 721–746.
Yozozaki, H., Takekura, N., Takanashi, A., Tabuchi, J., Haruta, R. & Tahara, E. (1988). Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis. Virchows Archiv [A] 413: 297–302.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Karat, D., Brotherick, I., Shenton, B. et al. Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study. Br J Cancer 80, 1271–1274 (1999). https://doi.org/10.1038/sj.bjc.6990497
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6990497
Keywords
This article is cited by
-
Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma
Gastric Cancer (2022)
-
Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women
Gastric Cancer (2022)
-
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer
The Pharmacogenomics Journal (2017)
-
Parity and gastric cancer risk: a systematic review and dose-response meta-analysis of prospective cohort studies
Scientific Reports (2016)
-
Expression profile and prognostic role of sex hormone receptors in gastric cancer
BMC Cancer (2012)